Dispute centered around licensing agreements and intellectual property
DryCool cuts MR helium requirement from 1,500 liters to less than one liter
Announcement comes shortly after health system filed Chapter 11 bankruptcy
Section on 'Labeling' may be concerning for right-to-repair advocates
Sonio offers the FDA-cleared Sonio Detect
Points to molecular imaging and MR as growth drivers
Utilizing data to refine AI-driven algorithms on syngo.via PET/CT software
The eight-story hospital is first designated free-standing children’s hospital in the region
Swoop portable MR distributors coming to France, UK and Italy
The aim is to improve the health system’s oncology, cardiovascular, and neurovascular care
Philip Jacobus launched DOTmed.com in 1998. He has been involved in health care since 1977, when he visited China to sell equipment. He has done business in over 35 countries and still travels extensively. Phil is active in charity, helps rural clinics and always tries to help DOTmed users when he can.
Phil is a member of AHRA, AAMI, HFMA and the Cryogenic Society of America. He has contributed to a number of magazines and journals and has addressed trade groups.
Phil's proudest achievement is that he has been happily married to his wife Barbara since 1989, who helped him found DOTmed in 1998.
Insights from Dr. Mark Crockett, chief medical officer of TeleDaaS
Insights from Dr. Joseph Webb, CEO of Nashville General Hospital
Insights from Shawn Luke, technical marketing engineer at DigiKey
Insights from Dr. Sulagna Misra, founding physician at Misra Wellness
Insights from Dan Draper, founder and CEO of CipherStash, a data security company that utilizes searchable encryption technology
Insights from Dr. Yolanda M. VanRiel, an RN associate professor and department chair of nursing at North Carolina Central University
Insights from Katie Pearson, director of operations at Northside Hospital Cherokee; Lynn Jackson, CEO of Northside Hospital Forsyth; and Carolyn Booker, chief nursing officer at Northside Hospital Forsyth
Insights from Catherine Ofori-Atta, senior clinical operations lead at Roche and Sandra Amaro, head of clinical trial diversity at Pfizer